Bookmark and Share
LYPLA2 (geneid:11313) - Gene BioActivity Data
Also known as: RP5-886K2.5, APT-2, DJ886K2.4.
BioActivity Outcomes:
Active(62)
 
 
Inactive(205)
 
 
Unspecified(4)
 
 
BioAssay Types:
Literature(7)
 
 
 
 
Confirmatory(5)
 
 
 
 
BioActivity Types:
IC50(3)
 
 
 
Substance Types:
Chemical(264)
 
 
 
 
RNAi(7)
 
 
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 15    Data Row: 271   Total Pages: 6   Display: Page     
Sort: [Click the result table header to sort]
#StructureSubstanceCompoundActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID160654496]
[CID16193817]
0.144Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical dose-response gel-based ABPP [AID651990_2, Type: confirmatory] [gi:9966764]
View
2
[SID160654495]
[CID16193817]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: LCMS-based cell-based Activity-Based Protein Profiling (ABPP) SILAC selectivity analysis in situ [AID651980_1, Type: other] [gi:9966764]
View
3
[SID160654495]
[CID16193817]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition and selectivity [AID651988_2, Type: other] [gi:9966764]
View
4
[SID160654496]
[CID16193817]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical gel-based ABPP evaluation of activity in situ [AID651986_2, Type: other] [gi:9966764]
View
5
[SID160654496]
[CID16193817]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical gel-based ABPP gel filtration assay to assess binding mode [AID651987_2, Type: other] [gi:9966764]
View
6
[SID92709352]
[CID24792060]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] [gi:9966764]
View
7
[SID160709325]
[CID70697710]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1: LCMS-based Activity-Based Protein Profiling (ABPP) SILAC selectivity analysis in vitro, Set 2 [AID652018_2, Type: other] [gi:9966764]
View
8
[SID92709310]
[CID4173716]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] [gi:9966764]
View
9
[SID92709351]
[CID24792905]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] [gi:9966764]
View
10
[SID92709354]
[CID1810599]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] [gi:9966764]
View
11
[SID92709358]
[CID7628255]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] [gi:9966764]
View
12
[SID92709371]
[CID6520605]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] [gi:9966764]
View
13
[SID92709371]
[CID6520605]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition and selectivity [AID652030_1, Type: other] [gi:9966764]
View
14
[SID92709365]
[CID3597028]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] [gi:9966764]
View
15
[SID134314021]
Genome-wide high-content siRNA screens for regulators of Parkin translocation in selective mitophagy (Dharmacon Library) [AID651810, Type: Literature] [geneid:11313]
View
16
[SID160709328]
[CID70697696]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1: LCMS-based Activity-Based Protein Profiling (ABPP) SILAC selectivity analysis in vitro, Set 2 [AID652018_2, Type: other] [gi:9966764]
View
17
[SID160709335]
[CID70697702]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1: LCMS-based Activity-Based Protein Profiling (ABPP) SILAC selectivity analysis in vitro, Set 2 [AID652018_2, Type: other] [gi:9966764]
View
18
[SID160709341]
[CID70697705]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1: LCMS-based Activity-Based Protein Profiling (ABPP) SILAC selectivity analysis in vitro, Set 2 [AID652018_2, Type: other] [gi:9966764]
View
19
[SID160709342]
[CID70697695]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1: LCMS-based Activity-Based Protein Profiling (ABPP) SILAC selectivity analysis in vitro, Set 2 [AID652018_2, Type: other] [gi:9966764]
View
20
[SID160709332]
[CID70697687]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1: LCMS-based Activity-Based Protein Profiling (ABPP) SILAC selectivity analysis in vitro, Set 2 [AID652018_2, Type: other] [gi:9966764]
View
21
[SID4245654]
[CID3240101]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition and selectivity [AID652030_1, Type: other] [gi:9966764]
View
22
[SID7974398]
[CID735660]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition and selectivity [AID652030_1, Type: other] [gi:9966764]
View
23
[SID14728505]
[CID6917582]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition and selectivity [AID652030_1, Type: other] [gi:9966764]
View
24
[SID49640730]
[CID1130125]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition and selectivity [AID652030_1, Type: other] [gi:9966764]
View
25
[SID49715467]
[CID24789646]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition and selectivity [AID652030_1, Type: other] [gi:9966764]
View
26
[SID92709227]
[CID5213]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] [gi:9966764]
View
27
[SID92709233]
[CID2571709]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] [gi:9966764]
View
28
[SID92709234]
[CID24789599]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] [gi:9966764]
View
29
[SID92709238]
[CID3236902]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] [gi:9966764]
View
30
[SID92709239]
[CID2837966]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] [gi:9966764]
View
31
[SID92709242]
[CID1343676]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] [gi:9966764]
View
32
[SID92709254]
[CID738164]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] [gi:9966764]
View
33
[SID92709262]
[CID3237838]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] [gi:9966764]
View
34
[SID92709240]
[CID2843709]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] [gi:9966764]
View
35
[SID92709271]
[CID2162197]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] [gi:9966764]
View
36
[SID92709273]
[CID2810354]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] [gi:9966764]
View
37
[SID92709275]
[CID3243472]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] [gi:9966764]
View
38
[SID92709277]
[CID6036769]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] [gi:9966764]
View
39
[SID92709279]
[CID1377323]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] [gi:9966764]
View
40
[SID92709280]
[CID3232214]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] [gi:9966764]
View
41
[SID92709285]
[CID1316101]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] [gi:9966764]
View
42
[SID92709285]
[CID1316101]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition and selectivity [AID652030_1, Type: other] [gi:9966764]
View
43
[SID92709284]
[CID2768219]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] [gi:9966764]
View
44
[SID92709288]
[CID1280564]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] [gi:9966764]
View
45
[SID92709291]
[CID2252839]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] [gi:9966764]
View
46
[SID92709291]
[CID2252839]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition and selectivity [AID652030_1, Type: other] [gi:9966764]
View
47
[SID92709292]
[CID6621246]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] [gi:9966764]
View
48
[SID92709289]
[CID11839291]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] [gi:9966764]
View
49
[SID92709301]
[CID9548123]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] [gi:9966764]
View
50
[SID92709303]
[CID11839276]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] [gi:9966764]
View